Cyclin D1 Overexpression and Prognosis in Colorectal Adenocarcinoma

作者: Kiyoshi Maeda , Yong-suk Chung , Soon-myoung Kang , Masafumi Ogawa , Naoyoshi Onoda

DOI: 10.1159/000011849

关键词:

摘要: Recently, it has been reported that cyclin D1 plays a major role in oncogenesis various cancers; however, there have few studies on the association of overexpression and prognosis patients with malignant tumors. We evaluated prognostic significance colorectal adenocarcinoma. One hundred twenty-three specimens resected from adenocarcinomas were investigated by staining monoclonal antibody against D1. As result, both overall survival disease-free significantly poorer tumors strongly positive for than those cyclin-D1-negative or weakly The 5-year rate was 53.3%, while rates 96.2 78.8%, respectively. Moreover, multivariate analysis indicated is an independent predictor disease recurrence our patients. In conclusion, may be useful as

参考文章(25)
A. Hart, A. Balm, R. Michalides, E. Wientjens, B. Loftus, N. Van Veelen, Overexpression of Cyclin D1 Correlates with Recurrence in a Group of Forty-seven Operable Squamous Cell Carcinomas of the Head and Neck Cancer Research. ,vol. 55, pp. 975- 978 ,(1995)
David R. Cox, Regression Models and Life-Tables Springer Series in Statistics. ,vol. 34, pp. 527- 541 ,(1992) , 10.1007/978-1-4612-4380-9_37
Burton Eisenberg, Jerome J. Decosse, Frank Harford, Joel Michalek, Carcinoma of the colon and rectum:The natural history reviewed in 1704 patients Cancer. ,vol. 49, pp. 1131- 1134 ,(1982) , 10.1002/1097-0142(19820315)49:6<1131::AID-CNCR2820490611>3.0.CO;2-T
Cheryl Gillett, Paul Smith, Walter Gregory, Michael Richards, Rosemary Millis, Gordon Peters, Diana Barnes, Cyclin D1 and prognosis in human breast cancer International Journal of Cancer. ,vol. 69, pp. 92- 99 ,(1996) , 10.1002/(SICI)1097-0215(19960422)69:2<92::AID-IJC4>3.0.CO;2-Q
JGA Houbiers, SH van der Burg, LMG van de Watering, RAEM Tollenaar, A Brand, CJH van de Velde, CJM Melief, Antibodies against p53 are associated with poor prognosis of colorectal cancer. British Journal of Cancer. ,vol. 72, pp. 637- 641 ,(1995) , 10.1038/BJC.1995.386
Yutaka Yonemura, Itasu Ninomiya, Shigekazu Ohoyama, Hironobu Kimura, Akio Yamaguchi, Sachio Fushida, Ituo Miyazaki, Yoshio Endou, Motohiro Tanaka, Takuma Sasaki, Takeo Kosaka, Kouichi Miwa, Expression of c-erbB-2 oncoprotein in gastric carcinoma. Immunoreactivity for c-erbB-2 protein is an independent indicator of poor short-term prognosis in patients with gastric carcinoma. Cancer. ,vol. 67, pp. 2914- 2918 ,(1991) , 10.1002/1097-0142(19910601)67:11<2914::AID-CNCR2820671134>3.0.CO;2-G
R Michalides, P Hageman, H van Tinteren, L Houben, E Wientjens, R Klompmaker, J Peterse, A clinicopathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer. British Journal of Cancer. ,vol. 73, pp. 728- 734 ,(1996) , 10.1038/BJC.1996.128
Toru Motokura, Theodora Bloom, Hyung Goo Kim, Harald Jüppner., Joan V. Ruderman, Henry M. Kronenberg, Andrew Arnold, A novel cyclin encoded by a bcl1 -linked candidate oncogene Nature. ,vol. 350, pp. 512- 515 ,(1991) , 10.1038/350512A0